3.33Open3.33Pre Close0 Volume25 Open Interest15.00Strike Price0.00Turnover101.92%IV6.02%PremiumDec 20, 2024Expiry Date2.29Intrinsic Value100Multiplier6DDays to Expiry1.04Extrinsic Value100Contract SizeAmericanOptions Type0.8753Delta0.0904Gamma7.06Leverage Ratio-0.0396Theta0.0021Rho6.18Eff Leverage0.0046Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet